Preoperative staging of biliary carcinoma using 18 F-fluorodeoxyglucose PET: Prospective comparison with PET+CT, MDCT and histopathology

European Radiology

Volumn 18, Issue 12, 2008, Pages 2841-2847

  Furukawa, Hiroyoshi ^a   Ikuma, Hiroki ^a   Asakura Yokoe, Koiku ^a   Uesaka, Katsuhiko ^a  

^a SHIZUOKA CANCER CENTER   (Japan)

Author keywords

Biliary neoplasms; Biliary surgery; Neoplasm staging; Positron emission tomography; Spiral computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; IOPAMIDOL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CANCER STAGING; CLINICAL TRIAL; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

BILE DUCT NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE CARE; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 56349114895     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-008-1062-2     Document Type: Article

References (29)

1. de Groen PC, Gores GJ, LaRusso NF, Gunderson LL, Nagorney DM (1999) Biliary tract cancers. N Eng J Med 341:1368-1378
2. Hu H, He HD, Foley WD, Fox SH (2000) Four multidetector-row helical CT: image quality and volume coverage speed. Radiology 215:55-62
3. Schulte SJ, Baron RL, Teefey SA, Rohrmann CA, Freeny CA, Schuman WP, Foster MA (1990) CT of the extrahepatic bile ducts: Wall thickness and contrast enhancement in normal and abnormal ducts. AJR 154:79-85
4. Ohtani T, Shirai Y, Tsukada K, Hatakeyama K, Muto T (1993) Carcinoma of the gallbladder: CT evaluation of lymphatic spread. Radiology 189:875-880
5. Chun KA, Ha HK, Yu ES, Shin KS, Kim KW, Lee DH, Kang SW, Auh YH (1997) Xanthogranulomatous cholecystitis: CT features with emphasis on differentiation from gallbladder carcinoma. Radiology 203:93-97
6. Tillich M, Mischinger HJ, Preisegger KH, Rabl H, Szolar DH (1998) Multiphasic helical CT in diagnosis and staging of hilar cholangiocarcinoma. AJR 171:651-658
7. Feydy A, Vilgrain V, Denys A, Sibert A, Belghiti J, Vullierme MP, Menu Y (1999) Helical CT assessment in hilar cholangiocarcinoma: Correlation with surgical and pathologic findings. AJR 172:73-77
8. Yoshimitsu K, Honda H, Shinozaki K, Aibe H, Kuroiwa T, Irie H, Chijiiwa K, Aasayama Y, Masuda K (2002) Helical CT of the local spread of carcinoma of the gallbladder: Evaluation according to the TNM system in patients who underwent surgical resection. AJR 179:423-428
9. Choi SH, Han JK, Lee JM, Lee KH, Kim SH, Lee JY, Choi BI (2005) Differentiating malignant from benign common bile duct stricture with multiphasic helical CT. Radiology 236:178-183
10. Som P, Atkins HL, Bandoypadhyay D, Fowler JS, MacGregor RR, Matsui K, Oster ZH, Sacker DF, Shiue CY, Turner H, Wan C-N, Wolf AP, Zabinski SV (1980) A fluorinated glucose analog, 2-fluoro-2-deoxy-D-glucose (F-18): nontoxic tracer for rapid tumor detection. J Nucl Med 21:670-675
11. Flier JS, Mueckler MM, Usher P, Lodish HF (1987) Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 235:1492-1495
12. Keiding S, Hansen SB, Rasmussen HH, Gee A, Kruse A, Roelsgaard K, Tage-Jensen U, Dahlerup JF (1998) Detection of cholangiocarcinoma in primary sclerosing cholangitis by positron emission tomography. Hepatology 28:700-706
13. Koh T, Taniguchi H, Yamaguchi A, Kunishima S, Yamagishi H (2003) Differential diagnosis of gallbladder cancer using positron emission tomography with fluorine-18-labeled fluoro-deoxyglucose (FDG-PET). J Surg Oncol 84:74-81
14. Kluge R, Schmidt F, Caca K, Barthel H, Hesse S, Georgi P, Seese A, Huster D, Berr F (2001) Positron emission tomography with (18F)fluoro-2-deoxy-D-glucose for diagnosis and staging of bile duct cancer. Hepatology 33:1029-1035
15. Fritscher-Ravens A, Bohuslavizki KH, Broering DC, Jenicke L, Schäfer H, Buchert R, Rogiers X, Clausen M (2001) FDG PET in the diagnosis of hilar cholangiocarcinoma. Nucl Med Commun 22:1277-1285
16. Kato T, Tsukamoto E, Kuge Y, Katoh C, Nambu T, Nobuta A, Kondo S, Asaka M, Tamaki N (2002) Clinical role of 18F-FDG PET for initial staging of patients with extrahepatic bile duct cancer. Eur J Nucl Med 29:1047-1054
17. Anderson CD, Rice MH, Pinson CW, Chapman WC, Chari RS, Delbeke D (2004) Fluorodeoxyglucose PET imaging in the evaluation of gallbladder carcinoma and cholangiocarcinoma. J Gastrointest Surg 8:90-97
18. Reinhardt MJ, Strunk H, Gerhardt T, Roedel R, Jaeger U, Bucerius J, Sauerbruch T, Biersack HJ, Dumoulin FL (2005) Detection of Klatskin's tumor in extrahepatic bile duct strictures using delayed 18F-FDG PET/CT: preliminary results for 22 patient studies. J Nucl Med 46:1158-1163
19. Petrowsky H, Wildbrett P, Husarik DB, Hany TF, Tam S, Jochum W, Clavien PA (2006) Impat of integrated positron emission tomography and computed tomography on staging and management of gallbladder cancer and cholangiocarcinoma. J Hepatol 45:43-50
20. Furukawa H, Ikuma H, Seki A, Aramaki T, Yuen S, Yamaguchi S (2006) PET scanning is not superior to whole-body multi-detector helical computed tomography in the preoperative staging of colorectal cancer. Gut 55:1007-1011
21. Friess H, Langhans J, Ebert M, Berger HG, Stollfuss J, Reske SH, Büchler MW (1995) Diagnosis of pancreatic cancer by 2(18F)-fluoro-2-deoxy-d-glucose positron emission tomography. Gut 36:771-777
22. Zimmy M, Bares R, Fab J, Adam G, Cremerius U, Dohmen B, Kelver P, Sabri O, Schumpelick V, Buell U (1997) Fluorine-18 fluorodeoxyglucose positron tomography in the differential diagnosis of pancreatic carcinoma: A report of 106 cases. Eur J Nucl Med 24:678-682
23. Delbeke D, Rose DM, Chapman WC, Pinson CW, Wright JK, Beauchamp RD, Shyr Y, Leach SD (1999) Optimal interpretation of FDG-PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 40:1784-1791
24. Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, Spaulding MB (1998) Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: Correlation with histopathologic and CT findings. Radiology 2006:755-760
25. Kantorová I, Lipská L, Bělohlávek O, Visokai V, Trubač M, Schneiderová M (2003) Routine 18F-FDG PET preoperative staging of colorectal cancer: Comparison with conventional staging and its impact on treatment decision making. J Nucl Med 44:1784-1788
26. Arulampalam THA, Costa DC, Loizidou M, Visvikis D, Ell PJ, Taylor I (2001) Positron emission tomography and colorectal cancer. Br J Surg 88:176-189
27. Glsbrenner B, Ardan M, Boeck W, Preclik G, Möller P, Adler G (1999) Prospecrive evaluation of brush cytology of biliary strictures during endoscopic retrograde cholangiopancreatography. Endoscopy 31:712-717
28. Foutch PG (2002) Diagnosis of cancer by cytologic methods performed during ERCP. Gastrointest Endosc 56:720-730
29. Mansfield JC, Griffin SM, Wadehra V, Mathewson K (1997) A prospective evaluation of cytology from biliary strictures. Gut 49:671-677